Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

Summary

The purpose of this study is to determine the safety and benefit of Thalidomide with primary sclerosing cholangitis (PSC). This is a six month study.

Timeline

Start

2006-04

Primary completion

2009-05

Completion

2009-05

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of enrollment”

Drugs

Indications